A worrisome habit is arising among some American politicians. They don’t like what scientists conclude about some supposedly controversial topic so they try to defund the research. A good example of this tactic is climate change—in recent months, we’ve heard of efforts to limit NASA, EPA, NOAA, and NSF funding for research in geoscience. But I wonder whether there’s a fatal flaw here.
If you believe fervently that either the planet isn’t warming up—despite the recent finding that 2015 was the hottest on record—or, if it is, that humans are not contributing to the rise, then it might seem prudent to provide abundant funding to climate scientists so that they can arrive at the truth and vindicate your beliefs. But what if these scientists are finding that there’s no evidence of warming but are lying about it—perhaps because they hold left-leaning views that seek to achieve public support for alternative energy, or maybe they are chagrined that the reason the earth is not warming from the burning of fossil fuels is their models are flawed? Ah, a conspiracy!
Despite the oft-cited evidence that at least 97% of the scientists in this field expressing a view on the subject support the consensus that humans are contributing to the planet’s warming, maybe all those scientists—worldwide—are in on the conspiracy.
If you believe in this vast scientific conspiracy, it seems to me that you can’t have much faith in the view of reality that science proffers. Fine, you can hold any beliefs you want. But if virtually all climate scientists are untruthful, can you have faith that others in similar professions, say biologists and physicians, are honest?
Let’s consider a medical example. Some of those disbelieving the consensus on climate change are likely to have high LDL cholesterol (the bad form), a “supposed” risk factor for heart disease. As a consequence, they may have been given a prescription by their doctors for a class of drugs known as statins. They likely were dutiful in filling their prescription and now take a pill everyday that contains a statin. But I have to ask: should these patients be taking this pill?
Why would anyone believe that statins lower LDL cholesterol? Well, scientists would be quick to cite studies that “demonstrated” just this outcome, such as an influential Scandinavian study in the 1990s that “showed” that statin treatment could reduce cholesterol levels and led to a 30% decrease in the risk of death over the trial period. But could those researchers who carried out that study have been secretly paid by a pharmaceutical company to show that statins were effective even though they weren’t? And maybe similar shenanigans happened for all the other published studies on statin efficacy. Ah, a conspiracy!
“Wait a second,” says our climate change denier with high cholesterol. “I personally had my blood tested before I went on the statin, and my LDL cholesterol really was high, and then I had it tested after being on the statin for awhile, and it came way down. So the drug truly does work.”
“Not so fast,” I reply. “Surely you didn’t perform the blood tests yourself, using your own home chemistry kit? Your blood was probably sent to a clinical lab that performed the tests and reported the results back to your doctor. If that’s the case, there were plenty of chances for some pharmaceutical company to have paid the testing lab to falsely reduce your LDL number. Or maybe your doctor was the one in on the payout and changed the number? Or maybe there was no money involved but your physician wouldn’t accept an unchanged LDL reading because she erroneously believes that high cholesterol contributes to a heart attack and wants you to continue on your new diet? Or maybe your physician has left-leaning views that argue for reducing beef consumption because raising cattle is a horrendous waste of resources? And come to think of it, how do we even know that any drug is even present in that pill that you’ve been taking? Never underestimate the placebo effect.”
Reality sits precariously atop a steep and slippery slope. If you push hard enough on it, don’t be surprised when it rolls all the way to the ground. And once it arrives there, ask yourself how sure you are that those other drugs you may take for hypertension, cancer, diabetes, hepatitis or any other condition work “as advertised.”
As geneticists, should we care if climate research is defunded, other than that the earth may become a lot more inhospitable to our children and grandchildren? Sure we should. If this tactic works, maybe the next target for defunding is stem cells. Or vaccines. Or studies that rely on evolutionary principles. Or Drosophila development and C. elegans neurobiology. Or even: investigations into the causes and treatment of heart disease.
Stan Fields is Immediate Past President of the Genetics Society of America. The views expressed in his posts are his and are not necessarily endorsed by the Society.
View all posts by Stan Fields »Read more in
-
Early Career Leadership Spotlight: Julio Molina Pineda
We’re taking time to get to know the members of the GSA’s Early Career Scientist Committees. Join us to learn more about our early career scientist advocates. Julio Molina Pineda Policy and Advocacy University of Arkansas Research Interest My research interests focus on using model organisms to genetically dissect complex traits related to human disease. My…
-
Early Career Leadership Spotlight: Peiwei Chen
We’re taking time to get to know the members of the GSA’s Early Career Scientist Committees. Join us to learn more about our early career scientist advocates. Peiwei Chen Accessibility Subcommittee California Institute of Technology Research Interest Far from a harmonious place, the genome is a battleground, where every bit of DNA fights for inheritance and…
-
#Dros23 GSA Poster Award winners
We are pleased to announce the GSA Poster Award winners from the 64th Annual Drosophila Research Conference! Undergraduate and graduate student members of the GSA were eligible for the awards, and a hard-working team of postdocs volunteered their time as judges. Congratulations to all! Undergraduate Students 1st Place: Sofia Karter Lopez, University of Toronto “Rab11 mediates E-cadherin recycling during…
-
Congratulations to the Fall 2022 DeLill Nasser Awardees!
GSA is pleased to announce the recipients of the DeLill Nasser Award for Professional Development in Genetics for Fall 2022! Given twice a year to graduate students and postdoctoral researchers, DeLill Nasser Awards support attendance at meetings and laboratory courses. The award is named in honor of DeLill Nasser, a long-time GSA supporter and National Science Foundation…
-
New editors join GENETICS, G3 editorial boards
Several new editors are joining the GSA Journals. We’re excited to welcome Ricardo Zayas to the GENETICS editorial board under the Molecular Genetics of Development section, and on the G3: Genes|Genomes|Genetics board, we welcome Polly Campbell, Kevin Vogel, Joe Parker, and Ricardo Mallarino. Ricardo Zayas Associate Editor Ricardo Zayas is a Professor of Biology at…
-
Worms and Flies Provide Key Clues to Medical Mystery
This article is part of a series of posts outlining the history and impact of research in experimental organisms. The series is developed in collaboration with the GSA Public Communications and Engagement Committee. By the time Bertrand Might was six months old, it was clear something was amiss. His muscles weren’t developing normally; he was…
-
Congratulations to the 2023 Early Career Leadership Program Cohort!
The Genetics Society of America (GSA) is excited to announce the latest cohort of student, postdoc, and early-career research leaders joining the Early Career Leadership Program. Participants receive training and mentoring while serving on committees charged with understanding the needs, interests, concerns, and challenges of early career scientist members of the GSA. As part of…
-
GSA LOCI: Local Outreach Community Initiatives @ GSA Conferences
Highlights: Local Outreach Community Initiatives (LOCI): The Genetics Society of America is committed to supporting the communities of the host cities of our conferences. This new year, we are excited to reconnect with our GSA community in meaningful ways within and beyond our existing programming. The GSA membership has created a caring and supportive environment…
-
New members of the GSA Board of Directors: 2023–2025
We are pleased to announce the election of five new leaders to the GSA Board of Directors: 2023 Vice President/2024 President Mariana Wolfner Distinguished Professor of Molecular Biology and Genetics and Stephen H. Weiss Presidential Fellow My research has focused on the genes and pathways that mediate sexual development and reproduction, primarily in Drosophila. From…
-
Lance David Miller: Lighting Your Own Fire by Finding the Right Resources
By Daniel J. Gironda In the Paths to Science Policy series, we talk to individuals who have a passion for science policy and are active in advocacy through their various roles and careers. The series aims to inform and guide early career scientists interested in science policy. This series is brought to you by the…
-
Graça Almeida-Porada: The Importance of Communication in a Technologically Advancing World
By Daniel J. Gironda In the Paths to Science Policy series, we talk to individuals who have a passion for science policy and are active in advocacy through their various roles and careers. The series aims to inform and guide early career scientists interested in science policy. This series is brought to you by the…